July 13, 2025 a 11:43 am
MRNA: Fundamental Ratio Analysis - Moderna, Inc.
Moderna, Inc. operates in the biotechnology sector, primarily focusing on mRNA therapeutics and vaccines. With a range of products targeting infectious diseases and cancer, the company has positioned itself strategically in the healthcare market. Despite challenges, Moderna's innovations present significant growth potential.
Fundamental Rating
Moderna's fundamental rating provides insights into its financial health and growth prospects. The overall rating is 'C+', indicating moderate performance with room for improvement.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return On Equity | 1 | |
| Return On Assets | 1 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 4 |
Historical Rating
Comparing historical scores reveals stability in Moderna's financial performance. Recent scores slightly improved, indicating potential growth.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-11 | 2 | 3 | 1 | 1 | 3 | 1 | 4 |
| Previous | 2 | 3 | 1 | 1 | 3 | 1 | 4 |
Analyst Price Targets
Analyst estimates suggest a balanced outlook with a strong consensus for holding shares.
| High | Low | Median | Consensus |
|---|---|---|---|
| 50 | 45 | 47.5 | 47.5 |
Analyst Sentiment
Analyst sentiment reflects a mixed perspective, with a predominant inclination towards holding the stock.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 9 | |
| Hold | 13 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Moderna, Inc. holds a promising position in the biotechnology industry with its innovative mRNA-based solutions. While its current financial ratings exhibit average performance, the company’s robust pipeline and strategic alliances offer substantial growth opportunities. Investors should weigh these against the inherent risks associated with the volatile healthcare sector and consider the mixed analyst sentiments when making investment decisions.